(Hypertension. 1996;27:202-208.)
© 1996 American Heart Association, Inc.
Articles |
From the Groningen Institute for Drug Studies (of Groningen Utrecht Institute for Drug Exploration), Department of Medicine, Division of Nephrology, State University Hospital, Groningen, Netherlands.
Correspondence to D. de Zeeuw, MD, PhD, Department of Medicine, Division of Nephrology, State University Hospital, Hanzeplein 1, 9713 RB Groningen, Netherlands.
Abstract Many patients with essential hypertension respond to a high dietary sodium intake with a rise in blood pressure. Experimental evidence suggests that the renal hemodynamic response to sodium determines, at least partially, this rise in blood pressure. Our aim was to clarify the role of the renin-angiotensin system in the renal and systemic adaptation to a change in dietary sodium. We studied changes in mean arterial pressure (MAP) (millimeters of mercury), effective renal plasma flow (ERPF), body weight, and immunoreactive renin in 17 patients with essential hypertension and 15 normotensive control subjects, randomly crossing over between a 3-week sodium-restricted (50 mmol/24 h) and a sodium-replete (200 mmol/24 h) diet period. In addition, the effects of renin inhibition by remikiren (600 mg, single oral dose) were studied during the high sodium period. In normotensive control subjects, high sodium intake had no effect on MAP or body weight, whereas ERPF increased (490±19 to 535±21 mL/min, P<.05) and immunoreactive renin decreased (32±6 to 14±1 pg/mL). In hypertensive subjects, high sodium intake induced a heterogeneous response of MAP (median change, 2.6 mm Hg; range, -4.7 to +21.2; P=NS) and ERPF (median change, 21 mL/min; range, -33 to +98; P=NS). Body weight increased from 81.3±1.9 to 82.5±2.0 kg (P<.05), and immunoreactive renin decreased from 18±3 to 10±1 pg/mL (P<.05). Interestingly, the patients with a distinct rise in MAP showed a blunted ERPF response to high sodium intake (r=-.70, P<.01) and an increase in body weight (r=.76, P<.001). Moreover, the increase of ERPF was more pronounced in patients with a larger fall in immunoreactive renin (r=.77, P<.001). After administration of remikiren, a heterogeneous response in ERPF was observed: the patients with the blunted ERPF response to high sodium intake showed the largest ERPF rise (r=.70, P<.01). The remikiren-induced rise in ERPF correlated (r=.68, P<.01) with the fall in MAP (114±2 to 110±2 mm Hg). In conclusion, in patients with essential hypertension a rise in blood pressure in response to high sodium intake appears to partially be the result of insufficient renal vasodilation. This seems to be due to an inadequate (intrarenal?) renin-angiotensin system response to increased sodium intake.
Key Words: renal hemodynamics blood pressure sodium renin inhibition remikiren
This article has been cited by other articles:
![]() |
O. Schmidlin, A. Forman, A. Sebastian, and R. C. Morris Jr Sodium-Selective Salt Sensitivity: Its Occurrence in Blacks Hypertension, December 1, 2007; 50(6): 1085 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Sanders, G. E. Fazzi, G. M.J. Janssen, C. E. Blanco, and J. G.R. De Mey High Sodium Intake Increases Blood Pressure and Alters Renal Function in Intrauterine Growth-Retarded Rats Hypertension, July 1, 2005; 46(1): 71 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Kerstens, F. G. H. van der Kleij, A. H. Boonstra, W. J. Sluiter, J. Koerts, G. Navis, and R. P. F. Dullaart Salt Loading Affects Cortisol Metabolism in Normotensive Subjects: Relationships with Salt Sensitivity J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4180 - 4185. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J He and G. A MacGregor Review: Salt, blood pressure and the renin-angiotensin system Journal of Renin-Angiotensin-Aldosterone System, March 1, 2003; 4(1): 11 - 16. [Abstract] [PDF] |
||||
![]() |
G. D Laverman, D. de Zeeuw, and G. Navis Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy? Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 205 - 213. [Abstract] [PDF] |
||||
![]() |
H. Schachinger, M. Weinbacher, A. Kiss, R. Ritz, and W. Langewitz Cardiovascular Indices of Peripheral and Central Sympathetic Activation Psychosom Med, September 1, 2001; 63(5): 788 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chiolero, G. Wurzner, and M. Burnier Renal determinants of the salt sensitivity of blood pressure Nephrol. Dial. Transplant., March 1, 2001; 16(3): 452 - 458. [Full Text] [PDF] |
||||
![]() |
P. V. PAASSEN, D. D. ZEEUW, P. E. D. JONG, and G. NAVIS Renin Inhibition Improves Pressure Natriuresis in Essential Hypertension J. Am. Soc. Nephrol., October 1, 2000; 11(10): 1813 - 1818. [Abstract] [Full Text] |
||||
![]() |
A. Chiolero, M. Maillard, J. Nussberger, H.-R. Brunner, and M. Burnier Proximal Sodium Reabsorption : An Independent Determinant of Blood Pressure Response to Salt Hypertension, October 1, 2000; 36(4): 631 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Schmidlin, A. Forman, M. Tanaka, A. Sebastian, and R. C. Morris Jr NaCl-Induced Renal Vasoconstriction in Salt-Sensitive African Americans : Antipressor and Hemodynamic Effects of Potassium Bicarbonate Hypertension, February 1, 1999; 33(2): 633 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Messerli, R. E. Schmieder, and M. R. Weir Salt: A Perpetrator of Hypertensive Target Organ Disease? Arch Intern Med, November 24, 1997; 157(21): 2449 - 2452. [Abstract] [PDF] |
||||
![]() |
M. M. E. Krekels, N. C. Schaper, and P. W. de Leeuw Sensitivity of Blood Pressure and Renin Activation During Sodium Restriction Hypertension, November 1, 1997; 30(5): 1216 - 1222. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |